# Low Remifentanil Target Controlled Infusions for Cardiac Surgery

> **NCT02033629** · PHASE3 · COMPLETED · sponsor: **Imam Abdulrahman Bin Faisal University** · enrollment: 75 (actual)

## Conditions studied

- Cardiac Surgery

## Interventions

- **DRUG:** Ce 1 ng/ml
- **DRUG:** Ce 2 ng/ml
- **DRUG:** Ce 3 ng/ml

## Key facts

- **NCT ID:** NCT02033629
- **Lead sponsor:** Imam Abdulrahman Bin Faisal University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2019-05-01
- **Final completion:** 2019-05-15
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2019-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02033629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02033629, "Low Remifentanil Target Controlled Infusions for Cardiac Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02033629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*